ZyVersa Therapeutics's total assets for Q4 2025 were $347.90M, an increase of 33343.66% from the previous quarter. ZVSA total liabilities were $12.73B for the fiscal quarter, a 99656.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.